NextCure, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-06-18 EDT			5-day change	1st Jan Change
2.020 ^USD	-8.18%		-9.42%	-85.76%

06-02	NextCure, Inc. - Special Call
06-01	NextCure, Inc. Presents Positive SIM0505 Phase 1 Dose Escalation Data In Patients With Gynecologic Cancers At ASCO	CI

Published on 06/02/2026 at 11:50 am EDT - Modified on 06/02/2026 at 05:20 pm EDT

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good morning, and welcome to the NextCure Virtual KOL event. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

06-02	NextCure, Inc. - Special Call
06-01	NextCure, Inc. Presents Positive SIM0505 Phase 1 Dose Escalation Data In Patients With Gynecologic Cancers At ASCO	CI
05-07	NextCure, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-04	Nextcure, Inc. and Simcere Zaiming Pharmaceutical Co., Ltd. Initiate Dose Optimization for SIM0505 (CDH6 ADC) in Gynecologic Cancers	CI
04-07	NextCure Inc Receives Fast Track Designation For SIM0505 In Ovarian Cancer	CI
03-31	NextCure Inc and Simcere Zaiming Pharmaceutical Co Ltd Abstract for SIM0505 is Accepted for ASCO 2026	CI
03-05	NextCure, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-04	NextCure, Inc. Auditor Raises 'Going Concern' Doubt	CI
01-23	Nextcure, Inc. Provides Updates for Its Two Antibody Drug Conjugate Programs	CI
01-23	NextCure provides business update	RE
11-26	NextCure files for offering of up to 2.52 million shares of common stock by selling stockholders - SEC filing	RE
11-16	NextCure, Inc. announced that it has received $21.498209 million in funding from Ikarian Capital, LLC, Squadron Capital Management Llc, Affinity Asset Advisors, LLC, Exome Asset Management LLC	CI
11-11	NextCure, Inc. announced that it expects to receive $21.500024 million in funding	CI
11-05	Biopharmaceutical firm NextCure Q3 net loss narrows	RE
11-05	NextCure, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI